Power Integrations Launches 1700 V GaN Switcher IC, Setting New Benchmark for Gallium Nitride Technology
Reading Time: 3 minutes San Jose, Calif., United States: Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today introduced a new member of its InnoMux™-2 family of single-stage, independently regulated multi-output offline power supply ICs. The new device features
An Unforgettable Night of Sufi Magic
Reading Time: 3 minutes iluzn Club & Kitchen, Gurugram’s premier destination for immersive nightlife, is thrilled to announce “Bismil Ki Mehfil,” an unforgettable night featuring the one and only Bismil, on Saturday, 9th November, from 10:30 PM onwards. The event serves as an exclusive afterparty for Bismil’s highly successful
Kesko updates its sustainability strategy
Reading Time: 3 minutes Kesko has updated its sustainability strategy, setting emission reduction targets for its own operations extending to 2034. Over the next 10 years, Kesko will be increasing its investments in energy efficiency and the electrification of transports in an effort to reduce emissions.
OCBC Forms Strategic Partnership With Ant International to Enhance the Efficiency of Cross-Border Fund Settlements Through Innovations in Tokenised Deposits
Reading Time: 3 minutes Singapore: OCBC and Ant International have formed a strategic partnership to enhance the efficiency and speed of cross-border fund settlements. In a Memorandum of Understanding (MoU) signed on 5 November 2024 by Melvyn Low, Head of Global Transaction Banking at OCBC,and
BLA for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) accepted for priority review by the U.S. FDA
Reading Time: 2 minutes Stockholm, November 5, 2024: Immedica announces today that the Biologics License Application (BLA) for pegzilarginase in the treatment of arginase 1 deficiency (ARG1-D) has been successfully validated and accepted for priority review by the U.S. Food and Drug Administration (FDA). Anders
DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed
Reading Time: 3 minutes The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 7 October 2024 has been completed today, 5 November 2024, following expiry of a 4-week notice period (“proklama”). As set out in press release published
Noble Corporation plc Provides Guidance
Reading Time: < 1 minute SUGAR LAND, TEXAS, Nov. 5, 2024 /PRNewswire/ – Noble Corporation plc (“Noble”) (CSE: NOBLE, NYSE: NE) today provides guidance for the quarter ended December 31, 2024. In accordance with Danish legal and stock exchange requirements, Noble announced that for the quarter
Noble Corporation plc Announces Third Quarter 2024 Results and Additional Share Repurchase Authorization
Reading Time: 16 minutes • Closed Diamond acquisition on September 4th • Increased capital return program with additional share repurchase authorization of $400 million • Repurchased 6.9 million of shares in Q3 2024, $0.50 per share dividend declared for Q4 2024, bringing total FY 2024 cash
Nordea Bank Abp: Repurchase of own shares on 05.11.2024
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares05.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 05.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
Nytida acquires Friab’s operations within individual and family care
Reading Time: 2 minutes Nytida, part of the Ambea Group, acquires the care provider Friab’s operations in foster homes, HVB homes (homes for care or residence) and assisted living facilities. The operations included in the acquisition are units within foster home care, four HVB homes